Kalytera Therapeutics Will Meet with the FDA to Discuss Cannabidiol as a Possible Treatment For Acute GVHD
889520 / Pixabay

Kalytera Therapeutics Will Meet with the FDA to Discuss Cannabidiol as a Possible Treatment For Acute GVHD

Kalytera Therapeutics, Inc. has announced that a meeting with the Centre for Drug Evaluation and Research of the US FDA is planned for Tuesday, 31st July this year. The purpose of…

Continue Reading Kalytera Therapeutics Will Meet with the FDA to Discuss Cannabidiol as a Possible Treatment For Acute GVHD
ICYMI: New Investigational Treatment Could be a Step Forward Against Graft-versus-Host Disease
source: pixabay.com

ICYMI: New Investigational Treatment Could be a Step Forward Against Graft-versus-Host Disease

According to a story from Financial Buzz, the pharmaceutical company Elsayls Biotech is planning to submit a proposal to the European Medicines Agency (EMA) in order to conduct a clinical…

Continue Reading ICYMI: New Investigational Treatment Could be a Step Forward Against Graft-versus-Host Disease